What You Need to Know about Safer Inhalation. Ontario Harm Reduction Conference FEBRUARY 2013
|
|
- Brianna Daniels
- 5 years ago
- Views:
Transcription
1 What You Need to Know about Safer Inhalation Ontario Harm Reduction Conference FEBRUARY
2 Indicators of urgent necessity to implement safer inhalation initiatives Evidence of prevalence of engagement in smoking crack Evidence of HIV and HCV transmission risk associated with smoking crack Evidence of safer inhalation program success Evidence of need for provincial mandate 2
3 Street name for cocaine dissolved and cooked in mixture of water and baking soda to form rocks Crack from crackling noise when rock of crack is heated Extremely addictive associated with compulsive behaviors, restlessness, exhaustion, tension and paranoia Popularity: non-invasive intense high 5 10 minutes low cost $10 wide availability
4 Baseline evaluation of the Ontario Harm Reduction Distribution Program May 2007 March ,643 active IDUs from 26 Public Health Units in Ontario 62% smoked crack in 6 months prior to interview 64% at least once a week 19% three or more times a week 24% daily Average number of times per day smoked crack 24 times (Range ) 4
5 I-Track - Enhanced Surveillance of Risk Behaviors among Injecting Drug Users in Canada ,031 women and men who inject drugs 63% reported smoking crack in the 6 months prior to interview Higher rates of engagement documented for Toronto 89% Edmonton 84% Winnipeg 75%
6
7
8 8
9
10
11 Devices EVER Used to Smoke Crack Recommended 83% Glass stems NON Recommended 79% Metal pipe 74% Pop can 69% Inhalers 21% Car antenna 13% Light bulb 11
12 Two conditions must be met to facilitate transmission and acquisition of HIV and HCV HCV RNA or HIV RNA must be present in biological fluids; and Trauma to a mucous membrane presenting as opportunistic site for virus entry. Chronic cuts, burns, blisters and open sores inside mouth and on lips are a consequence of sustained contact with: Hot smoke and hot metal from makeshift devices. Splintered and hot glass from unprotected stems no mouthpiece. These injuries act as opportunistic blood sharing sites allowing direct virus-to-blood interaction when smoking devices contaminated with infected blood are shared.
13
14 Epidemiological role of non-injection drug use in HIV infection examined in a number of studies Smoking crack an independent risk factor for HIV seroconversion among daily users of crack. (DeBeck et al., 2009) Non-injection drug use independently associated with HIV prevalence among Chinese female sex workers. (Wang et al., 2009)
15 Epidemiological role of non-injection drug use in HCV infection examined in a number of studies Sharing crack pipes when blood present associated with higher prevalence of HCV among 722 crack smokers with no history of IDU (OR 12.78, CI 1.12,145.29). (Howe et al., 2005) Sharing crack inhalation equipment independently associated with HCV prevalence among 182 Spanish non-idus, elevating risk three fold (AOR=3.6; CI 1.3, 9.8). (Macias, 2008)
16 Multiperson Use of Devices to Smoke Crack Smoking with previously-used drug-smoking equipment 78% 54% Every time/frequently Passing on previously-used devices to others to use 78% 49% Every time/frequently 16
17 street-recruited active crack smokers in Ottawa Laboratory results of saliva testing HIV prevalence among 89 dual users (smoking crack and injecting other drugs) 20.2% (95%CI: 12.4, 30.0) HIV prevalence among 160 JUST crack smokers 10.6% (95%CI: 6.3, 16.5)
18 street-recruited active crack smokers Laboratory results of saliva testing HCV prevalence among 89 dual users (smoking crack and injecting other drugs) 87% (95%CI: 77.6, 92.8) HCV prevalence among 160 JUST crack smokers 36% (95%CI: 28.2, 43.6)
19 April 2005 Ottawa Public Health (OPH) expanded its existing Clean Needle and Syringe Program services to include the provision of safer inhalation equipment glass stems, mouthpieces, brass screens and push sticks. 10 community agencies, partner agencies of OPH, also distributed safer inhalation equipment in addition to safer injection and drug preparation equipment. Results of evaluation: Program Uptake - immediate, high and sustained Risk Behaviors - decline in sharing crack-smoking equipment Drug Use - significant decrease in injecting drugs Access to Harm Reduction Services over 4,000 visits made by people who only smoke crack July 2007 Program cancelled
20 August the Ontario Minister of Health s Advisory Committee on HIV/AIDS (OACHA) and the Minister s Advisory Committee on Hepatitis C (The Hepatitis C Task Force) sent a letter to the Health Minister expressing serious concerns about the cancellation of the Safer Crack Use Initiative at Ottawa Public Health and making recommendations to mitigate the impact of that decision November the Ontario Minister of Health met with former CEO Dr Robert Cushman of the Champlain LHIN, Jack McCarthy of the Somerset West Community Health Centre and other community partners to discuss the urgent need created in Ottawa as a result of the Ottawa City Council decision to cancel the Safer Crack Use Initiative December 2007 the Minister agreed to fund an alternative Safe Inhalation Program in Ottawa at the Somerset West Community Health Centre July 2008 Safe Inhalation Program operational
21 Services Available Safer inhalation supplies Supportive information, counseling and health teaching related to risk reduction and disease prevention Testing for HIV, Hepatitis and sexually transmitted infections Safer disposal of used equipment Referrals to health and social services Community clean ups
22 Three rounds of interviews (n 250 each) August June 2009 provided data for four time points. Time Point PRE-implementation Effect Baseline 2 months POST-implementation Immediate effect 6 months POST-implementation Middle-range effect 11 months POST-implementation Long-range effect To assess the impact of the SIP, we compared data from PRE and POST time points.
23 PRE vs. POST 11 Months Reports of UNAVAILABLE SUPPLIES significantly decreased 47 to 11% p Reports of INSUFFICIENT AMOUNTS of supplies significantly decreased 31 to 8% p 0.001
24 PRE vs. POST 11 Months Smoking with RECOMMENDED glass stem increased 89 to 93%
25 PRE vs. POST 11 Months Smoking with NON-RECOMMENDED makeshift devices significantly decreased Metal pipes 40 to 11% p Car antennae 7 to 1% p Pop cans 42 to 15% p Inhalers 44 to 17% p 0.001
26 PRE vs. POST 11 Months Reports of SMOKING WITH PREVIOUSLY-USED DEVICES significantly decreased 65 to 53% p 0.01
27 PRE vs. POST 11 Months Reports of PASSING ON PREVIOUSLY-USED DEVICES to others to use significantly decreased 64 to 49% p 0.001
28 POST 2 Months vs. POST 11 Months Mean NUMBER OF TIMES STEM RE-USED BEFORE DISPOSAL significantly decreased 288 to 40 times p 0.001
29 Ottawa s Safe Inhalation Program had an initial positive impact Increased community accessibility to safer inhalation devices in Ottawa Engagement in smoking with safer smoking devices increased Engagement in HIV- and HCV-related risk behaviors declined but remain high
30 Politics Killed Crack-Pipe Program Ottawa Citizen July 14, 2007 The City s chief MOH repeatedly told Council that the program was working, saving lives, saved millions in future medical expenses and was good for public health in the city before it was cancelled. He added that scientific evidence backed up these claims and an internationally recognized study of the program concluded that it was working. His message fell on deaf ears as council struck down the program. 30
31 Politics Killed Crack-Pipe Program Ottawa Citizen July 14, 2007 there was clear evidence the program was working to help stem the spread of HIV and hepatitis C amongst the city's drug users, but that it was so unpopular with the general public, many city councilors and the Mayor voted to kill it instead of risking turning off voters. 31
32 The decision to kill the program was politically motivated, and it shows Council is not living up to its role as a Board of Health. Obviously we are not up to the task. When people are ignoring the clear advice of our chief medical officer of health, there s a huge problem. Councillor Peggy Feltmate, Ottawa Citizen, 14 July
33 The police chief himself has written to me about the fact that he has had his officers confiscating pipes from people. That is, in my mind, interfering with my program. Dr David Salisbury, Medical Officer of Health, Ottawa CBC News, January
34 SWCHC SIP Evaluation POST-2-Months vs. POST-11- Months Level of comfort carrying around NEW/UNUSED safer crack-smoking supplies An increasing and substantial proportion reported they DID NOT feel comfortable Reasons for discomfort Fear of police (range: 58-68%) 41 to 44% Conditions of bail/probation (range: 11-17%) Judgment by others (range: 3-12%) 34
35 OHRDP Evaluation Police taken clean glass stems in six months prior to interview? Ottawa 24% 1 50 times Toronto 41% 1 50 times Kingston 17% 1 2 times Guelph 16% 1 6 times 35
36 Reasons for Non-distribution of Safer Inhalation Supplies Among 20 Public Health Units not distributing 55% Distribution not approved by MOH or Regional Board of Health 23% No financing available to purchase 22% Supplies not available for distribution 10% Not yet sought approval from PHU 36
37 ON THE BASIS OF THE EVIDENCE Of the documented successful impacts of safer inhalation programs in Ontario in modifying the risk environment for women and men who smoke crack. Of the documented ability of Boards of Health, law enforcement personnel and Medical Officers of Health (MOHs) to negatively impact successful harm reduction programs. IT IS RECOMMENDED THAT The distribution of safer inhalation resources, including educational materials, be distributed thorough the Ontario Harm Reduction Distribution Program and that each Regional MOH be directed by the Provincial MOH to comply with the distribution. 37
38 Improving Services for People in Ottawa who Smoke Crack Dr Lynne Leonard x 8286
Preventing Harm from Substance Use: Harm Reduction. July 6, Dr. Murray Fyfe Medical Health Officer Vancouver Island Health Authority
Preventing Harm from Substance Use: Harm Reduction July 6, 2009 Dr. Murray Fyfe Medical Health Officer Vancouver Island Health Authority Substance Dependence Substance use spans from abstinence, to beneficial
More informationDrugs. Cocaine is most commonly found in powder form and is snorted. Cocaine is a drug derived from the coca plant.
SECTION: COCAINE AND CRACK Overview Cocaine is a stimulant and is extremely addictive. Cocaine is most commonly found in powder form and is snorted. Cocaine is a drug derived from the coca plant. Crack
More informationOperational Guideline
1 of 6 PURPOSE Prevention of the spread of sexually transmitted and blood-borne infections (STBBI) through distribution of harm reduction supplies SCOPE & GOAL Harm reduction supplies and condoms will
More informationCrack Pipe FAQs: What service providers need to know. Presenter: Andrew Ivsins
Crack Pipe FAQs: What service providers need to know Presenter: Andrew Ivsins Presentation objective Answer some common questions about crack pipe sharing. Provide an overview of current best practice
More informationProvincial Infectious Diseases Advisory Committee Public Health Response to Hepatitis C
Provincial Infectious Diseases Advisory Committee Public Health Response to Hepatitis C Dr. Doug Sider, Medical Director, Public Health Ontario Dr. Peggy Millson, Professor Emeritus, Dalla Lana School
More informationAs a result of this training, participants will be able to:
Addressing Sexual Risk with Drug Users and their Partners 1 Day Training This one-day training will build participant knowledge and skills in offering sexual harm reduction options to substance users.
More informationWhat Women and Men Who Smoke Crack Have to Say about HIV and Hepatitis C Prevention: Implications for Policy and Program Development
What Women and Men Who Smoke Crack Have to Say about HIV and Hepatitis C Prevention: Implications for Policy and Program Development FINAL STUDY REPORT May 2011 Aideen Reynolds MPA Lynne Leonard PhD Andree
More informationCarol Strike, PhD & Tara Marie Watson, PhD and the Working Group on Best Practice for Harm Reduction Programs in Canada
Carol Strike, PhD & Tara Marie Watson, PhD and the Working Group on Best Practice for Harm Reduction Programs in Canada Project goals and methods Reduce transmission of HIV and STBBI Improve the quality,
More informationOntario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario
Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario Views expressed in the attached document do not necessarily represent those of the Ministry of Health and Long Term Care or those
More informationQuestions & Answers. What are the risks associated with consumption drug use?
Questions & Answers What are the risks associated with consumption drug use? Consumption drug use affects us all. Harms associated with consumption drug use are many and include the spread of infectious
More informationNote: Staff who work in case management programs should attend the AIDS Institute training, "Addressing Prevention in HIV Case Management.
Addressing Prevention with HIV Positive Clients This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result in transmitting
More informationIDU Outreach Project. Program Guidelines
Ministry of Health and Long-Term Care Ministère de la Santé et des Soins de longue dureé Prepared by: AIDS Bureau Revision Date: April 2001 TABLE OF CONTENTS 1 Introduction...1 1.1 Program Goals... 2 1.2
More informationAs a result of this training, participants will be able to:
Addressing Prevention with HIV Positive Clients 1 Day Training This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result
More informationPresented by: Carol Strike, PhD, Associate Professor at the Dalla Lana School of Public Health, University of Toronto.
Best Practice Recommendations for Canadian harm reduction programs that provide service to people who use drugs and are at risk for HIV, HCV, and other harms: Part 1 Presented by: Carol Strike, PhD, Associate
More informationwho use drugs in order to assist them in reducing harm while in the cycle of addiction
August 16, 2016 } Accepts that illicit drug use is part of our world, and chooses to minimize its harmful effects rather than ignore or condemn them } Calls for the provision of services to people who
More informationSigns of success latest national NESI data?
Needle Exchange Surveillance Initiative Signs of success latest national NESI data? Alison Munro (University of the West of Scotland) Study partners Professor Avril Taylor Chief Investigator (UWS) Dr Alison
More informationHarm Reduction in Nigeria
Harm Reduction in Nigeria Needs, gaps, and responses to ensure access to effective HIV prevention, treatment and care for people who inject drugs February 2018 This document is made possible by the generous
More informationiphis Case ID #: Reported Date: Reporting Source: Diagnosing Health Unit: Branch Office: Outbreak Number:
Case Investigation Form: Hepatitis C Legend iphis system mandatory Required Case Information (add dates as YYYY-MM-DD) Case s Last Name: Case s First Name: Middle Name: Birth Date: Male Gender: Female
More informationTransmission/Prevention
Transmission/Prevention Section Three Transmission/Prevention Hepatitis C is transmitted by blood-to-blood contact. Any break in the skin may allow HCV to enter the body, even if no blood is visible. The
More informationHepatitis C Best Practice Guidelines For Local Health Departments
Hepatitis C Best Practice Guidelines For Local Health Departments LHDs are responsible for investigating and reporting all physician reported cases of acute hepatitis C (HCV). For clients known to have
More informationPART 2: BEST PRACTICE RECOMMENDATIONS
PART 2: BEST PRACTICE RECOMMENDATIONS FOR CANADIAN HARM REDUCTION PROGRAMS THAT PROVIDE SERVICE TO PEOPLE WHO USE DRUGS AND ARE AT RISK FOR HIV, HCV, AND OTHER HARMS Carol Strike and the Working Group
More informationBackground. Population/Intervention(s)/ Comparison/Outcome(s) (PICO)
updated 2012 Role of sterile injection equipment and outreach programmes for injecting drug users Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related
More informationEpidemiology of Acute Hepatitis C Infection in Canada Results from the Enhanced Hepatitis Strain Surveillance System (EHSSS)
Epidemiology of Acute Hepatitis C Infection in Canada Results from the Enhanced Hepatitis Strain Surveillance System (EHSSS) At a Glance Reported rates of acute HCV declined from.5 per, population in to.
More informationHIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons
HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons Ministerial Meeting on Urgent response to the HIV/AIDS epidemics in the Commonwealth of Independent States Moscow, 31 March
More informationMinistry of Health and Long-Term Care Overdose Prevention Sites: User Guide for Applicants
Ministry of Health and Long-Term Care Overdose Prevention Sites: User Guide for Applicants Population and Public Health Division Ministry of Health and Long-Term Care January 2018 INTRODUCTION On November
More informationPart 1: Introduction & Overview
Part 1: Introduction & Overview We envision a collaborative, participative partnership around IDU that: Provides all relevant and interested stakeholders with a voice and role. Promotes awareness of the
More informationInfectious and Communicable Diseases Prevention and Control Program Annual Service Plan A. Community Need and Priorities We are situated rurally with
Infectious and Communicable Diseases Prevention and Control Program Annual Service Plan A. Community Need and Priorities We are situated rurally with no access to walk in clinics and access to health care
More informationBuilding and enhancing capacity for HCV prevention; BC case scenario
Building and enhancing capacity for HCV prevention; BC case scenario Jane.Buxton@BCCDC.ca Physician epidemiologist hepatitis BCCDC Harm reduction lead 1 Main messages from BC: Good data is important Develop
More informationOntario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario
Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario Views expressed in the attached document do not necessarily represent those of the Ministry of Health and Long Term Care or those
More informationONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE. Dr. David Williams Chief Medical Officer of Health
ONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE Dr. David Williams Chief Medical Officer of Health National opioid-related mortality data, 2016 (Health Canada) Provincial Overdose Coordinator
More informationHepatitis C Basics. Michael Bailey Director of Programming, CATIE. Mary Choy Regional Health Education Coordinator, CATIE
Hepatitis C Basics Michael Bailey Director of Programming, CATIE Mary Choy Regional Health Education Coordinator, CATIE CATIE Our History Learning Objectives 1) To learn about the basics of hepatitis C
More informationWhat s The Harm? Conference 2015: Where are we now.what s Next? Beth Whalen
What s The Harm? Conference 2015: Where are we now.what s Next? Beth Whalen Harm reduction means a common sense, non-judgmental and pragmatic way of dealing with problems caused by the use of drugs. It
More informationHIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications
HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014
More informationRe: Revisions to the Communicable Disease Control Manual, Chapter 3- Infection Control
1 February 27, 2009 ATTN: Medical Health Officers and Branch Offices Public Health Nursing Administrators and Assistant Administrators Holders of Communicable Disease Control Manuals Re: Revisions to the
More informationOperational Guideline
Population and Public Health May 1 1 of 9 PURPOSE Engage people who may have been marginalized from mainstream services. Prevent the spread of sexually transmitted and blood-borne infections by providing
More informationWorking Group on Best Practice for Harm Reduction Programs in Canada. practices harm reduction
Working Group on Best Practice for Harm Reduction Programs in Canada Canada wide, inter sectoral team Carol Strike, U of T Shaun Hopkins, Toronto Public Health Tara Marie Watson, U of T Jane Buxton, UBC
More informationDrug Use, Harm Reduction, and HIP
Drug Use, Harm Reduction, and HIP Strategies for Engaging PWIDs in HIV Prevention Services Presented by: Katie Burk, MPH Narelle Ellendon, RN Harm Reduction Coalition Founded in 1993 by needle exchange
More informationMOBILE OUTREACH. A guide to help plan and implement a Mobile Outreach Vehicle (MOV)-based risk reduction intervention program.
This guide is designed to help Community-Based Organizations (CBOs) and other individuals or groups in the planning and implementation of a Mobile Outreach Vehicle (MOV)-based risk-reduction intervention
More informationFax completed form to: (204) Further inquiries: your CD Coordinator
Population and Public Health Program Acute Hepatitis B Virus (HBV) Enhanced Surveillance Case Report Form Fax completed form to: (204) 940-2690 Further inquiries: your CD Coordinator PERSON REPORTING Last
More informationOntario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario
Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario Views expressed in the attached document do not necessarily represent those of the Ministry of Health and Long Term Care or those
More informationThe new WHO global injection safety policy and campaign
The new WHO global injection safety policy and campaign B. Allegranzi, SDS, HIS WHO/USAID/PEPFAR hosted webinar 20 August 2015 Overuse of injections and unsafe injection practices worldwide in 2000 (1)
More informationBecoming a harm reduction distribution agency in Toronto - information session
Becoming a harm reduction distribution agency in Toronto - information session Kris Guthrie, RN BScN Health Promotion Specialist, The Works Toronto Public Health May 2016 Overview Brief backgrounder Harm
More informationPatient Care Planning Group April 3, 2014
Patient Care Planning Group April 3, 2014 Philip O. Toal, Ed.D,; LMHC, CET Administrator, Non-Residential Services The Center For Drug Free Living, a founding partner of Aspire Health Partners Participants
More informationOntario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario
Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario Views expressed in the attached document do not necessarily represent those of the Ministry of Health and Long Term Care or those
More informationGovernment of Canada Federal AIDS Initiative Milestones
HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for
More informationPrison needle exchange: Review of the evidence
Prison needle exchange: Review of the evidence Prepared for: Correctional Service Canada Prepared by: the Public Health Agency of Canada April 2006 PHAC PNEP Assessment Team: Dr. Thomas Wong (Team Leader)
More informationBuilding a New Approach to Health Care Services for Hard to Reach Clients
Building a New Approach to Health Care Services for Hard to Reach Clients Community Discussion and Open House January 30, 2013 Fernwood Community Association 1923 Fernwood Street February 6, 2013 North
More informationWHITEHORSE I-TRACK REPORT. Monitoring Risk Behaviour among People Who Inject or Inhale Drugs in Whitehorse, Yukon
WHITEHORSE I-TRACK REPORT Monitoring Risk Behaviour among People Who Inject or Inhale Drugs in Whitehorse, Yukon : Monitoring Risk Behaviour among People Who Inject or Inhale Drugs in Whitehorse, Yukon
More informationDetection of Hepatitis B and C in Primary Care
Detection of Hepatitis B and C in Primary Care Presentation 2 January 2016 Quality Quality Education Education for for aa Healthier Healthier Scotland Scotland 1 1 Learning Outcomes Participants will be
More informationLocal Legislative Approval and Program Certification
Syringe Services Programs: Implementation Brief St. Louis County, Missouri Introduction Syringe services programs (SSPs), also known as needle exchange or syringe access programs, are an integral component
More informationHCSP TRAINING MANUAL
HCSP TRAINING MANUAL SECTION IV: HCV TRANSMISSION AND PREVENTION Alan Franciscus, Editor-in-Chief The information in this guide is designed to help you understand and manage HCV and is not intended as
More informationQuADS Organisational Standards and Professional Competencies in needle exchange
QuADS Organisational Standards and Professional Competencies in needle exchange N This briefing paper was funded by the Department of Health as part of their 'Making Harm Reduction Work' initiative. DrugScope/Department
More informationStudy finds PEP not 100% effective in preventing HIV infection
From TreatmentUpdate 152 Study finds PEP not 100% effective in preventing HIV infection Some doctors and nurses who care for PHAs may sustain needle-stick injuries. This raises the possibility that they
More informationEnvironmental Scan, 2013
Environmental Scan, 2013 Abstract In March 2013, the Ontario Harm Reduction Distribution Program (OHRDP) launched an environmental scan of the 36 core Needle Syringe Programs (NSPs) associated with public
More informationThe Ontario Hepatitis C Multidisciplinary Team Model. Samantha Earl, RN, Senior Policy Analyst 2013 CATIE Forum Wednesday September 18, 2013
The Ontario Hepatitis C Multidisciplinary Team Model Samantha Earl, RN, Senior Policy Analyst 2013 CATIE Forum Wednesday September 18, 2013 History The Ontario Hepatitis Nursing Program was announced by
More informationHEPATITIS C, ACUTE CRUDE DATA. Number of Cases 5 Annual Incidence a LA County 0.05 California b 0.10 United States b 0.68 Age at Diagnosis Mean 38
2016 Annual Morbidity Report HEPATITIS C, ACUTE a Rates calculated based on less than 19 cases or events are considered unreliable b Calculated from: CDC. Notice to Readers: Final 2016 Reports of Nationally
More informationMercury : 1392BE15NP
2015 Objective measure the awareness and knowledge about the Hepatitis C virus among the Belgian population transmission prevention treatment Quota Belgian population 16-70 years old n=1000 Age Gender
More informationHIV Risk Behaviour in Irish Intravenous Drug Users
Abstract HIV Risk Behaviour in Irish Intravenous Drug Users A. Dorman, E. Keenan, C. Schuttler, J. Merry, J. J. O Connor The Drug Treatment Centre Board, Trinity Court, 30/31 Pearse Street, Dublin 2. The
More informationOmbudsman Toronto Enquiry Report. Cold Weather Drop-In Services City of Toronto Winter Season. May 12, 2017
Ombudsman Toronto Enquiry Report Cold Weather Drop-In Services City of Toronto 2016-17 Winter Season May 12, 2017 Introduction 1. On December 19, 2016, the CBC radio program, Metro Morning featured an
More informationCommunicable Diseases
Policy 1016 Elk Grove Police Department 1016.1 PURPOSE AND SCOPE This policy provides general guidelines to assist in minimizing the risk of department members contracting and/or spreading communicable
More informationMargot Kuo, Despina Tzemis, Ellison Richmond, Jane Buxton. CPHA 2012 June 12, 2012 Edmonton, AB
Margot Kuo, Despina Tzemis, Ellison Richmond, Jane Buxton CPHA 2012 June 12, 2012 Edmonton, AB Risks of smoking crack Risks of smoking crack Risk factor for HIV among people who inject (DeBeck et al. 2008)
More informationOntario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario
Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario Views expressed in the attached document do not necessarily represent those of the Ministry of Health and Long Term Care or those
More informationBloodborne Pathogens. Montclair Kimberley Academy 1
Bloodborne Pathogens Montclair Kimberley Academy 1 Introduction! Approximately 5.6 million workers in health care and other facilities are at risk of exposure to bloodborne pathogens such as human immunodeficiency
More informationOF THE REPUBLIC OF ARMENIA DECREE. 316 of 1 April 2002 Yerevan
Ratified President of the Republic of Armenia R. Kocharyan 1 April 2002 GOVERNMENT OF THE REPUBLIC OF ARMENIA DECREE 316 of 1 April 2002 Yerevan On ratification of the National Programme on HIV/AIDS Prevention
More informationNeedle and Syringe Programs - 17 October 2013
Needle and Syringe Programs - 17 October 2013 ANCD Position Paper: Needle and Syringe Programs MEDIA RELEASE 17 October 2013 The Australian National Council on Drugs (ANCD) has today released a position
More informationOpportunities For Hepatitis C Modalities in Substance Use Treatment Settings
Opportunities For Hepatitis C Modalities in Substance Use Treatment Settings KATIE BURK, MPH VIRAL HEPATITIS COORDINATOR SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH 1 Webinar Outline 1. HCV Overview 2. SFDPH
More informationThe Bloodborne Pathogen Standard. An Overview
The Bloodborne Pathogen Standard An Overview The Standard l In 1990, OSHA (Occupational Safety and Health Administration), developed the Bloodborne Pathogen Standard to protect workers by limiting occupational
More informationARTICLE IN PRESS. International Journal of Drug Policy xxx (2007) xxx xxx. Research Paper
International Journal of Drug Policy xxx (2007) xxx xxx Research Paper I inject less as I have easier access to pipes Injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources
More informationCOMMUNITY CONSULTATION SERIES Women Who Have Sex With Women (WSW) and HIV Prevention
COMMUNITY CONSULTATION SERIES Women Who Have Sex With Women (WSW) and HIV Prevention Presented by: The Institute @ Harm Reduction Coalition May 14, 2010 Harm Reduction Coalition Founded in 1994 to work
More informationWorking Group on Best Practice for Harm Reduction Programs in Canada.
Working Group on Best Practice for Harm Reduction Programs in Canada Canada-wide, inter-sectoral team Carol Strike, U of T Shaun Hopkins, Toronto Public Health Tara Marie Watson, U of T Jane Buxton, UBC
More informationOverview of Evidence for Sterile Syringe Access. Hilary McQuie Western Director Harm Reduction Coalition
Overview of Evidence for Sterile Syringe Access Hilary McQuie Western Director Harm Reduction Coalition Working Definition of Harm Reduction Harm Reduction: A set of practical, public health strategies
More informationPromoting hepatitis B vaccination
Promoting hepatitis B vaccination Introduction Hepatitis B is a serious blood borne infection that can exacerbate hepatitis C infection, can cause serious liver damage and sometimes results in death. Hepatitis
More informationNarrative report of HIV Preventive programmes in the Slovak Republic as of 31-st December 2013
Narrative report of HIV Preventive programmes in the Slovak Republic as of 31-st December 2013 1. Introduction HIV/AIDS pandemic is a human, social and economic disaster, with far-reaching implications
More informationImproving NSP and Harm Reduction Services. Jason Farrell, European HCV and Drug Use Initiative
Improving NSP and Harm Reduction Services Jason Farrell, European HCV and Drug Use Initiative Presentation Overview With the growing need to treat HCV, NSP programs have been identified in numerous stakeholder
More informationHARM REDUCTION IN CANADA LESSONS LEARNED AND REFLECTIONS. Marilou Gagnon, RN, PhD Associate Professor School of Nursing University of Victoria
HARM REDUCTION IN CANADA LESSONS LEARNED AND REFLECTIONS Marilou Gagnon, RN, PhD Associate Professor School of Nursing University of Victoria OUTLINE Harm reduction Canadian context Lessons learned 1.
More informationAdvocating for Syringe Exchange Programs
Advocating for Syringe Exchange Programs AMERICAN BAR ASSOCIATION AIDS COORDINATING COMMITTEE HIV Law & Practice Conference 2018 New Orleans, LA February 22, 2018 William McColl Vice President for Policy
More informationDISCLOSURE ESPACE GAIA, FIRST DCR IN PARIS SINCE OCTOBER /06/2017
ESPACE GAIA, FIRST DCR IN PARIS SINCE OCTOBER 2016 First results and perspectives DISCLOSURE DR Elisabeth AVRIL Presentation : Espace GAIA, first DCR in Paris : first results and perspectives Mundipharma,
More informationStrategies of drug users to avoid infection with hepatitis C
With financial support from the Drug Prevention and Information Programme of the European Union Strategies of drug users to avoid infection with hepatitis C Results from five European countries Dr. Heike
More information21. Getting Tested for HIV
21. Getting Tested for HIV Objectives By the end of this session, group members will be able to: Describe the process of HIV testing. List reasons for getting tested for HIV. Background notes It is not
More informationQuestions may be directed totamara Chipperfield, Director of Mental Health and Addictions
Position Title: Classification: Department: Reporting to: Type: Location: Harm Reduction Peer Worker Support Worker ($20.26 - $24.40 per hour) Harm Reduction Practice Facilitator, Harm Reduction Contract/Term
More informationBlood Borne Pathogens. Becky Walch, R.N. Micheel Valdez, L.V.N.
Blood Borne Pathogens Becky Walch, R.N. Micheel Valdez, L.V.N. Examples of Blood Borne Pathogens Hepatitis B Hepatitis C Other Hepatitis HIV Hepatitis Hepatitis means inflammation of the liver. Hepatitis
More informationMAKE SMART INJECTION CHOICES INJECTION PROVIDERS GUIDE FOR SAFE INJECTIONS
MAKE SMART INJECTION CHOICES INJECTION PROVIDERS GUIDE FOR SAFE INJECTIONS MAKE SMART INJECTION CHOICES WHO recommends syringes with re-use prevention (RUP) features for all injections. RUP syringes with
More informationManagement of Exposure to Needlestick Injuries & Body Fluids
Management of Exposure to Needlestick Injuries & Body Fluids Clinical S.O.P. No.:28 Compiled by: Approved by: Review date: November 2016 DOCUMENT HISTORY Version Detail of purpose / change Author / edited
More informationNeedle and syringe distribution
Needle and syringe distribution facilitate use of a sterile needle and syringe for each injection and reduce transmission of human immunodeficiency virus (HIV), hepatitis C (HCV), hepatitis B (HBV), and
More informationAdditional North Carolina Projects
Additional North Carolina Projects William Zule, Dr.P.H. www.rti.org RTI International is a trade name of Research Triangle Institute Risk Groups Injecting drug users (IDUs) Non-injecting drug users (non-idus)
More informationBest Prac*ces Model for Harm Reduc*on in Bri*sh Columbia: Community Involvement
Best Prac*ces Model for Harm Reduc*on in Bri*sh Columbia: Community Involvement Authors: Despina Tzemis, Lianping Ti, Margot Kuo, Jennifer Campbell, Jane Buxton and the HRSS CommiAee Harm Reduc*on Program
More informationAustralian Injecting and Illicit Drug Users League. Policy Position Paper 8 Retractable Syringes
Australian Injecting and Illicit Drug Users League Policy Position Paper 8 Retractable Syringes June 2003 Discussion A retractable device is a combination needle and syringe where the needle goes back
More informationH1N1 Flu Virus Sudbury & District Health Unit Response. Shelley Westhaver May 2009
H1N1 Flu Virus Sudbury & District Health Unit Response Shelley Westhaver May 2009 Pandemic Influenza A global outbreak of disease that occurs when a new influenza virus appears or emerges in the human
More informationSAFER INJECTION SUPPLIES
SAFER INJECTION SUPPLIES CONCURRENT #1 1 Despina Tzemis, Health Promoter Ontario Harm Reduction Distribution Program (OHRDP) Kingston Community Health Centres OUTLINE OHRDP Process Video ~ Safer Drug Use
More informationTowards universal access
Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress
More informationPREVENTION STRATEGIES RELATED TO HIV/AIDS Narra Smith Cox, Ph.D., CHES
PREVENTION STRATEGIES RELATED TO HIV/AIDS Narra Smith Cox, Ph.D., CHES Background In Wisconsin the two primary modes of HIV transmission are unsafe sexual behavior and nonsterile injection practices. More
More informationThe role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009
The role of UNODC in working law enforcement agencies to promote harm reduction IHRC, Bangkok, 23 April 2009 Drug control has focused mostly on law enforcement Public health which is the first principle
More informationFrequently Asked Questions about HIV/AIDS: Transmission and Prevention How is HIV passed from one person to another?
Frequently Asked Questions about HIV/AIDS: Transmission and Prevention How is HIV passed from one person to another? HIV transmission can occur when blood, semen (including pre-seminal fluid or "pre-cum"),
More informationThe epidemiology of hepatitis C in Canada
The epidemiology of hepatitis C in Canada FACT SHEET Published 2017 This fact sheet provides a snapshot of the hepatitis C epidemic in Canada. It is one of a series of fact sheets providing epidemiological
More informationIMPORTANCE OF PEER-BASED SERVICES & NEEDLE & SYRINGE PROGRAMS (NSP)
IMPORTANCE OF PEER-BASED SERVICES & NEEDLE & SYRINGE PROGRAMS (NSP) Annie Madden Executive Officer Australian Injecting & Illicit Drug Users League (AIVL) SUMMARY Who is AIVL? 2 Harm Reduction Approaches:
More informationU.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs
U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs Michelle Van Handel, MPH Health Scientist National Center for HIV/AIDS, Viral Hepatitis, STDs and
More informationI TRACK Survey. Report June 1, 2006
I TRACK Survey Enhanced Surveillance of Risk Behaviours and Prevalence of HIV and Hepatitis C Among People Who Inject Drugs Report June 1, 2006 Prepared by: Epidemiology and Disease Control and Population
More informationHIV Prevention. Recent Advances and Implications for the Caribbean
HIV Prevention Recent Advances and Implications for the Caribbean Chris Behrens, MD CCAS/CHART Conference Barbados, August 2010 Cases 200 180 160 140 120 100 80 60 40 20 0 Year HIV Cases AIDS Cases HIV
More informationCOLLEGE'S RESPONSE TO AN INDIVIDUAL'S INABILITY TO WORK OR STUDY WITH A PERSON WITH A BLOOD-BORNE COMMUNICABLE DISEASE #2-01
Policy & Procedures Manual COLLEGE'S RESPONSE TO AN INDIVIDUAL'S INABILITY TO WORK OR STUDY WITH A PERSON WITH A BLOOD-BORNE COMMUNICABLE DISEASE #2-01 Approved: June 23, 1993 by: Board of Governors Effective:
More informationTO: Chair and Members, Board of Health for the City of Ottawa Health Unit, Mayor and Member of Ottawa City Council
M E M O / N O T E D E S E R V I C E TO: Chair and Members, Board of Health for the City of Ottawa Health Unit, Mayor and Member of Ottawa City Council DESTINATAIRE : Président et membres, Conseil de santé
More information